Body mass index as a predictive factor for efficacy of taxane-based chemotherapy in early breast cancer patients

被引：0
|
作者：
Garcia-Saenz, J. A. [1 ]
Spera, G. [2 ]
Pollan, M. A. [3 ]
Bermejo, B. [4 ]
Ruiz Borrego, M. [5 ]
Chan, A. [6 ]
Martin Jimenez, M. [7 ]
Guerrero Zotano, A. L. [8 ]
Calvo-Martinez, L. [9 ]
Rodriguez-Lescure, A. [10 ]
Arcusa Lanza, A. [11 ]
Chap, L. I. [12 ]
Crown, J. P. [13 ]
Bee-Munteanu, V. [14 ]
Casas, M. [15 ]
Polonio, O. [16 ]
Slamon, D. [17 ]
机构：
[1] Hosp Clin San Carlos, Dept Oncol, GEICAM Spanish Breast Canc Grp, Madrid, Spain
[2] TRIO Translat Res Oncol, Med, Montevideo, Uruguay
[3] Inst Salud Carlos III ISCIII, Natl Ctr Epidemiol, Madrid, Spain
[4] Hosp Clin Univ Valencia, Dept Med Oncol, GEICAM Spanish Breast Canc Grp, Valencia, Spain
[5] Hosp Univ Virgen del Rocio, Med Oncol, GEICAM Spanish Breast Canc Grp, Seville, Spain
[6] Curtin Med Sch, Med Oncol, Fac Hlth Sci, Bentley, Qld, Australia
[7] Hosp Gen Univ Gregorio Maranon, Serv Oncol Med Dept, IiSGM CIBERONC GEICAM Spanish Breast Canc Grp, Madrid, Spain
[8] IVO Fdn Inst Valenciano Oncol, Dept Med Oncol, GEICAM Spanish Breast Canc Grp, Valencia, Spain
[9] CHUAC Complejo Hosp Univ A Coruna, Med Oncol, GEICAM Spanish Breast Canc Grp, La Coruna, Spain
[10] Hosp Gen Univ Elche, Dept Med Oncol, GEICAM Spanish Breast Canc Grp, Elche, Spain
[11] Hosp Terrassa Consorci Sanitari Terrassa, Dept Med Oncol, Barcelona, Spain
[12] Beverly Hills Canc Ctr, Oncol, Beverly Hills, CA USA
[13] St Vincents Univ Hosp, Dept Med Oncol, Dublin, Ireland
[14] TRIO Translat Res Oncol, Project Management, Paris, France
[15] GEICAM Spanish Breast Canc Res Grp, Dept Stat, San Sebastian De Reyes, Spain
[16] GEICAM Spanish Breast Canc Res Grp, Sci, Madrid, Spain
[17] UCLA, Hematol Oncol, David Geffen Sch Med, Los Angeles, CA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
251P
引用
收藏
页码：S283 / S284
页数：2
相关论文
共 50 条
  • [41] A 20-gene signature in predicting the chemoresistance of breast cancer to taxane-based chemotherapy
    He, Dong-Xu
    Xia, Yu-Dong
    Gu, Xiao-Ting
    Jin, Jian
    Ma, Xin
    [J]. MOLECULAR BIOSYSTEMS, 2014, 10 (12) : 3111 - 3119
  • [42] Body mass index and response to neoadjuvant chemotherapy in breast cancer patients
    Litton, J. K.
    Gonzalez, A. M.
    Warneke, C. L.
    Kau, S.
    Buzdar, A. U.
    Bondy, M.
    Mahabir, S.
    Hortobagyi, G. N.
    Brewster, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Predicting toxicity of platinum and taxane-based chemotherapy in older patients with gynecologic cancer
    Yoshida, Hiroyuki
    Shintani, Daisuke
    Kawashima, Naoyuki
    Fujiwara, Keiichi
    [J]. JOURNAL OF BUON, 2020, 25 (02): : 736 - 742
  • [44] Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
    Hwang, Jun-Eul
    Hong, Ji-Yun
    Kim, Karham
    Kim, Seung-Hun
    Choi, Won-Young
    Kim, Min-Jee
    Jung, Sung-Hoon
    Shim, Hyun-Jeong
    Bae, Woo-Kyun
    Hwang, Eu-Chang
    Lee, Kyung-Hwa
    Lee, Jae-Hyuk
    Cho, Sang-Hee
    Chung, Ik-Joo
    [J]. BMC CANCER, 2013, 13
  • [45] Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
    Jun-Eul Hwang
    Ji-Yun Hong
    Karham Kim
    Seung-Hun Kim
    Won-Young Choi
    Min-Jee Kim
    Sung-Hoon Jung
    Hyun-Jeong Shim
    Woo-Kyun Bae
    Eu-Chang Hwang
    Kyung-Hwa Lee
    Jae-Hyuk Lee
    Sang-Hee Cho
    Ik-Joo Chung
    [J]. BMC Cancer, 13
  • [46] Taxane-based adjuvant chemotherapy reduces endothelin-1 and symmetric dimethylarginine levels in patients with breast cancer
    Alacacioglu, A.
    Kebapcilar, L.
    Sari, I.
    Gokgoz, Z.
    Tarhan, O.
    Somali, I.
    Yuksel, A.
    Bozkaya, G.
    Sop, G.
    [J]. JOURNAL OF BUON, 2010, 15 (03): : 572 - 576
  • [47] Combined PI3K and NOS inhibition enhances efficacy of taxane-based chemotherapy in metaplastic breast cancer
    Reddy, Tejaswini P.
    Mahboubi, Bijan
    Rosato, Roberto R.
    Guzman-Rojas, Liliana
    Qian, Wei
    Zhou, Jianying
    Kim, Baek
    Moulder, Stacy
    Piwnica-Worms, Helen
    Chang, Jenny C.
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [48] Qualitative assessment of dysgeusia in early breast cancer patients undergoing anthracycline or taxane-based standard chemotherapies
    Tsujimura, H.
    Yamada, M.
    Asako, E.
    Kodama, Y.
    Sato, T.
    Nabeya, Y.
    Nagase, H.
    Nakagawara, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S278 - S278
  • [49] Chemotherapy Response Assay Test and Prognosis for Breast Cancer Patients Who Have Undergone Anthracycline-and Taxane-Based Chemotherapy
    Lee, Anbok
    Lim, Woosung
    Moon, Byung-In
    Paik, Nam-Sun
    Koh, Suck-Hwan
    Song, Jeong-Yoon
    [J]. JOURNAL OF BREAST CANCER, 2011, 14 (04) : 283 - 288
  • [50] GSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients
    Zhang, Guochun
    Qian, Xueke
    Ren, Chongyang
    Wen, Lingzhu
    Lyu, Haitong
    Liao, Ning
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (02) : 655 - 663
12345